Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Quintiles, Synteract and MPI Research.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Stabilitech, Unilife, Genocea and Amarin.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, AMRI, ShangPharma and ERT.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC, Perceptive, Althea, Novella and BioClinica.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Protalix, Pevion, NeoStem and ProStraken.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Labs, NewAge Industries and Jennerex.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Roche, Caraco, CMP Therapeutics and Unilife.
in-PharmaTechnologist presents its weekly round up of movements in the pharma sector, including appointments at Genzyme, PharmAthene and Cadence Pharmaceuticals.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Genzyme, Amarin and Hard To Treat Diseases.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hospira, PTI, Migenix and Shrink Nanotechnologies.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Laxai, LabConnect, ERT and Avid Bioservices.
Outsourcing-Pharma presents its latest round-up of movements in the pharmaceutical outsourcing sector, including appointments at AAIPharma, NextPharma and Catalent.
in-PharmaTechnologist presents its latest round-up of movements in the pharmaceutical sector, including a new CEO at Caraco, appointments at Mylan and the return of the “Viking boss”.
Drug development services provider Aptuit has announced it is about
to invest $100m to expand its operations, just a few weeks after
completing two major acquisitions.
In-Pharmatechnologist's periodic round up of personnel moves in the
pharmaceutical sector includes a crop of new chief executives and
senior managers across the pharmachem, drug development and
manufacturing sectors.
Bristol-Myers Squibb has announced the sudden death of James
Palmer, aged 51, the firm's chief scientific officer and
president of the Pharmaceutical Research Institute. His death
occurred after undergoing surgery. Elliot Sigal,...
